KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Change in Cash: 2014-2024

Historic Change in Cash for BeOne Medicines (ONC) over the last 11 years, with Dec 2024 value amounting to -$547.2 million.

  • BeOne Medicines' Change in Cash rose 1286.91% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 480.20%. This contributed to the annual value of -$547.2 million for FY2024, which is 20.58% up from last year.
  • As of FY2024, BeOne Medicines' Change in Cash stood at -$547.2 million, which was up 20.58% from -$689.1 million recorded in FY2023.
  • In the past 5 years, BeOne Medicines' Change in Cash ranged from a high of $3.4 billion in FY2021 and a low of -$689.1 million during FY2023.
  • In the last 3 years, BeOne Medicines' Change in Cash had a median value of -$547.2 million in 2024 and averaged -$581.4 million.
  • As far as peak fluctuations go, BeOne Medicines' Change in Cash surged by 741.36% in 2020, and later crashed by 115.01% in 2022.
  • Yearly analysis of 5 years shows BeOne Medicines' Change in Cash stood at $769.2 million in 2020, then skyrocketed by 339.77% to $3.4 billion in 2021, then tumbled by 115.01% to -$507.9 million in 2022, then slumped by 35.68% to -$689.1 million in 2023, then climbed by 20.58% to -$547.2 million in 2024.